ABSTRACT
The worldwide dissemination of carbapenem-resistant Enterobacteriaceae (CRE) poses a critical human health issue by limiting the range of antibiotics that are usable in the treatment of common bacterial infections. Along with CRE, carbapenem heteroresistance has disseminated worldwide, which is described as different levels of carbapenem resistance within a seemingly isogenic bacterial population. Unstable carbapenem resistance will likely lead to unexpected treatment failure due to the enhanced resistance after initiation of treatment, contradicting antimicrobial susceptibility test results. Porin mutation and tandem amplification of the carbapenemase gene have been reported as mechanisms underlying enhanced carbapenem resistance. In this study, we identified multimerization of plasmids carrying carbapenemase genes, by using Southern blotting, whole-genome sequencing, and quantitative PCR (qPCR) analysis for the CRE isolates obtained in our previous surveillance in Osaka, Japan. Plasmids harboring a carbapenemase gene were multimerized by recA, likely through recombination at two consecutive sets of transposase genes of the IS91 family, thereby producing various plasmids of discrete sizes in a single bacterial cell of an Escherichia coli isolate. This multimerization resulted in increased copy numbers of carbapenemase genes, leading to enhanced gene transcription as well as carbapenem resistance. Prior exposure to meropenem further increased the copy number of carbapenemase genes, readily resulting in enhancement of carbapenem resistance. This mechanism may lead to clinical treatment failure by sifting antimicrobial resistance after the treatment initiation.
KEYWORDS: carbapenemase, plasmid multimerization, mechanism of antimicrobial resistance, carbapenem-resistant Enterobacteriaceae, recA
OBSERVATION
The rapid global dissemination of multidrug-resistant (MDR) Enterobacteriaceae threatens health care systems worldwide (1). Among MDR Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae (CRE) are of major concern because alternative treatment options are limited even against common bacterial infections. Carbapenem resistance is conferred primarily by carbapenemases, which hydrolyze carbapenems (2, 3). The level of carbapenem resistance differs among carbapenemase-producing isolates, with some carbapenemase producers exhibiting heteroresistance to carbapenems (4). Different levels of resistance to a particular antibiotic within a seemingly isogenic bacterial population, which is described as heteroresistance (5, 6), may lead to treatment failure of infectious diseases after the initiation of antibiotic therapy (7). Notably, heteroresistance against carbapenems has already spread worldwide (8, 9). There are several systems underlying enhancement of carbapenem resistance. To date, functional mutation of porins in the bacterial cell membrane that decreases their permeability to carbapenems (10, 11) and tandem amplification of plasmid-borne carbapenemase genes (4, 12, 13) have been reported to enhance carbapenem resistance. Although resistance-nodulation-division efflux systems extrude a wide variety of substrates, including different classes of antibiotics (14), the role of efflux pumps in expelling carbapenems in Enterobacteriaceae is controversial (15). Further analysis of mechanisms for enhanced carbapenem resistance is needed to investigate the associated mechanisms for heteroresistance. Thus, in this study, we report a novel mechanism for the enhancement of carbapenem resistance.
Among the CRE isolates obtained in our previous surveillance (4), we identified six chromosomally distinct Escherichia coli isolates (E042, E044, E058, E059, E114, and E244) that exhibited similar ladder patterns on Southern blot hybridization by use of a blaIMP-6 probe following S1 nuclease-digested pulsed-field gel electrophoresis (S1-PFGE) analysis (Fig. 1A). The ladder pattern bands were preserved even after the plasmids were conjugated into another E. coli strain, TUM3456 (Fig. 1B). However, whole-genome sequencing analysis of E. coli isolate E044 using a Nanopore GridION (Oxford Nanopore Technologies, UK) after treatment with an SQK-LSK109 1D ligation sequencing kit indicated that it carried only one IncN plasmid, pE044_IMP6, with a size of 53,449 bp; this plasmid exhibited 99.99% identity to and 93% coverage of plasmid pE188_IMP6 (Fig. 1C), which showed a single band by Southern blotting following S1-PFGE. pE188_IMP6 is a 52,715-bp IncN plasmid obtained from Klebsiella pneumoniae isolate E188 in our previous surveillance as a predominant blaIMP-6-carrying plasmid spreading in Osaka, Japan (4). In the sequence of pE044_IMP6, pE188_IMP6 was bracketed with three sets of transposase genes of the IS91 family. Southern blotting profiles indicated that these isolates carried multiple plasmids harboring blaIMP-6, and the plasmid sizes presented an arithmetic progression (Fig. 1A). The smallest plasmid was approximately 50 kbp, which was equal to the common difference of arithmetic progression, implying that these plasmids are multimers of a 50-kbp plasmid. The discrete sizes of the bands, even after treatment with proteinase K and nuclease S1, suggested that these bands did not represent an accumulation of monomers but that each band represented a single, circular multimer. Next, we compared the sequences of DNA fractions contained in each S1-PFGE band with the whole genome of isolate E044 (Fig. 1D). Each ladder band plasmid consisted of the DNA sequence of pE044_IMP6, without any other sequence of the whole chromosomal sequence of isolate E044. These results indicated that each S1-PFGE band represented multimerization of the 53-kbp plasmid, pE044_IMP6. The uniformity in the depth of reads from each band mapped on the pE044_IMP6 sequence indicated the absence of replicative amplification of insertion sequences, thereby implying that the plasmids were multimerized by homologous recombination and not by replicative transposition of insertion sequences (see Fig. S1 in the supplemental material) (16). Additionally, whole-genome sequencing analysis of isolate E044 using MinION for ultra-long-read sequencing confirmed the existence of sequence reads exhibiting plasmid multimers (Fig. 1E and F). The longest read was compared with pE044_IMP6, indicating multimerization of almost four monomer plasmids despite the low resolution (Fig. 1G; Fig. S2). All the monomer plasmids connected unidirectionally to form multimers without any monomer plasmid connected in the opposite direction (Fig. S2). This isolate exhibits multimerization of the clinically prevalent plasmid, which is considerably larger than the multimers of small plasmids reported to date (17–19).
Plasmid in isolate E044 was conjugated into E. coli strain ME9062 and its isogenic recA mutant, designated strains ME044 and JW044, respectively. Southern blotting hybridization using a blaIMP-6 probe following S1-PFGE analysis showed the disappearance of ladder pattern bands in the recA-deficient strain, JW044 (Fig. 1H). Plasmid in isolate JW044 was further conjugated into E. coli strain TUM3456 carrying wild-type recA, demonstrating the reproducibility of ladder pattern bands in the isolate (Fig. S3). We demonstrated that recA mediated the multimerization of the plasmids, likely through homologous recombination (17, 20). The difference between pE188_IMP6 and pE044_IMP6 was the presence of several copies of transposases suspected as the origin of multimerization. A comparison of the sequences of plasmids pE044_IMP6 and pJW044, which should be identical, further suggested that the recombination targeting two consecutive sets of transposase genes of the IS91 family caused the difference between the structures of these plasmids (Fig. S4).
We then investigated the effect of plasmid multimerization on antimicrobial resistance. Quantitative PCR (qPCR) revealed that strain ME044 cells harbored an increased copy number of blaIMP-6 when compared with strain JW044, whereas the copy number of blaIMP-6 in strain ME188 was not significantly different from that of JW188 (Fig. 2A). In addition, blaIMP-6 transcription and the MIC of meropenem were significantly higher for strain ME044 than for JW044 (Fig. 2B and C). These results indicated that the plasmid multimerization led to increased blaIMP-6 copy numbers and transcription in the bacterial cells, resulting in enhanced meropenem resistance. The presence of recA probably affects enhancement of meropenem resistance in ME188 or ME044 (21). However, the exceptional resistance to meropenem in ME044 compared with that of other transformants should be induced by increased blaIMP-6 transcription following plasmid multimerization.
Interestingly, preexposure to meropenem (overnight) increased the copy number of blaIMP-6 in ME044 cells (Fig. S5 and Fig. 2D), but it did not affect the copy number in ME188. This additional increase in blaIMP-6 copy number further enhanced the meropenem resistance of ME044 (Fig. 2E). Figure S6 shows the emergence of colonies within the inhibition zone of ME044, which exhibited higher resistance against meropenem after meropenem exposure. Exposure to meropenem is considered a burden on ME044 cells, increasing recA activity and subsequently inducing homologous recombination along with genome repair (22). These processes may cause increased plasmid multimerization, leading to increased blaIMP-6 copy numbers and enhanced meropenem resistance. However, increased blaIMP-6 copy number could also be due to the selection of the subpopulation carrying a higher number of multimers from a population that should be isogenic. Our results demonstrated the heterogeneity of blaIMP-6 copy numbers within seemingly isogenic clones, and meropenem exposure enhanced the resistance of the population through the increased copy number of blaIMP-6 in the population. Further analysis comparing maximum blaIMP-6 copy numbers in single cells should be conducted to confirm the promotion of multimerization via meropenem stimulation.
In conclusion, carbapenemase-encoding plasmids formed multimers within a bacterial cell of CRE isolates through recA function. This plasmid multimerization led to increased copy numbers of carbapenemase genes and enhancement of carbapenem resistance, and meropenem exposure resulted in a further increase in carbapenemase genes and enhanced resistance. This mechanism may underlie enhanced resistance to other antimicrobials and may likely cause eventual treatment failure of infectious diseases that initially respond to the treatment with antibiotics.
Data availability.
The whole-genome sequencing data are available from the DNA Data Bank of Japan (DDBJ) under accession numbers AP019404, LC590858, and LC594662. Raw sequence data of DNA fractions extracted from ladder band gels are available at NCBI under accession numbers DRX229219 to DRX229222. Raw data of E044 sequenced by MinION for ultra-long-read sequencing is available at NCBI under accession number DRX264853.
ACKNOWLEDGMENTS
We thank Yoshikazu Ishii at the Toho University Graduate School of Medicine for providing E. coli strain TUM3456 and the National BioResource Project (NIG, Japan) for providing E. coli strains ME9062 and JW2669-KC.
This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sport, Science and Technology in Japan and by the Japan Agency for Medical Research and Development (AMED) (grant numbers 20wm0225013h0001, 21wm0225013h0502, 20wm0125010h0001, 21wm0125010h0001).
R.A., Y.S., and Y.A. conceptualized the study design; R.A. and Y.M., performed the experiments; R.A., Y.A., Y.S., Y.M., and D.M. analyzed the data; R.A., Y.A., Y.S., K.T., T.I., and S.H. drafted and revised the manuscript. All authors revised and approved the final manuscript.
We declare that we have no competing interests.
Footnotes
Citation Abe R, Akeda Y, Sugawara Y, Matsumoto Y, Motooka D, Kawahara R, Yamamoto N, Tomono K, Iida T, Hamada S. 2021. Enhanced carbapenem resistance through multimerization of plasmids carrying carbapenemase genes. mBio 12:e00186-21. https://doi.org/10.1128/mBio.00186-21.
Contributor Information
Yukihiro Akeda, Email: akeda@biken.osaka-u.ac.jp.
Bruce R. Levin, Emory University
R. Craig MacLean, University of Oxford.
REFERENCES
- 1.World Health Organization. 2014. Antimicrobial resistance: global report on surveillance. World Health Organization, Geneva, Switzerland. https://www.who.int/drugresistance/documents/surveillancereport/en/. [Google Scholar]
- 2.David S, Reuter S, Harris SR, Glasner C, Feltwell T, Argimon S, Abudahab K, Goater R, Giani T, Errico G, Aspbury M, Sjunnebo S, EuSCAPE Working Group, ESGEM Study Group, Feil EJ, Rossolini GM, Aanensen DM, Grundmann H. 2019. Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread. Nat Microbiol 4:1919–1929. doi: 10.1038/s41564-019-0492-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17:1791–1798. doi: 10.3201/eid1710.110655. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Abe R, Akeda Y, Sugawara Y, Takeuchi D, Matsumoto Y, Motooka D, Yamamoto N, Kawahara R, Tomono K, Fujino Y, Hamada S. 2020. Characterization of the plasmidome encoding carbapenemase and mechanisms for dissemination of carbapenem-resistant Enterobacteriaceae. mSystems 5:e00759-20. doi: 10.1128/mSystems.00759-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Nicoloff H, Hjort K, Levin BR, Andersson DI. 2019. The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification. Nat Microbiol 4:504–514. doi: 10.1038/s41564-018-0342-0. [DOI] [PubMed] [Google Scholar]
- 6.El-Halfawy OM, Valvano MA. 2015. Antimicrobial heteroresistance: an emerging field in need of clarity. Clin Microbiol Rev 28:191–207. doi: 10.1128/CMR.00058-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Band VI, Weiss DS. 2019. Heteroresistance: a cause of unexplained antibiotic treatment failure? PLoS Pathog 15:e1007726. doi: 10.1371/journal.ppat.1007726. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Tan K, Nguyen J, Nguyen K, Huse HK, Nieberg PH, Wong-Beringer A. 2020. Prevalence of the carbapenem-heteroresistant phenotype among ESBL-producing Escherichia coli and Klebsiella pneumoniae clinical isolates. J Antimicrob Chemother 75:1506–1512. doi: 10.1093/jac/dkaa048. [DOI] [PubMed] [Google Scholar]
- 9.Sun JD, Huang SF, Yang SS, Pu SL, Zhang CM, Zhang LP. 2015. Impact of carbapenem heteroresistance among clinical isolates of invasive Escherichia coli in Chongqing, southwestern China. Clin Microbiol Infect 21:469.e1-10. doi: 10.1016/j.cmi.2014.12.013. [DOI] [PubMed] [Google Scholar]
- 10.Li X-Z, Plésiat P, Nikaido H. 2015. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev 28:337–418. doi: 10.1128/CMR.00117-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Nikaido H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol Rev 67:593–656. doi: 10.1128/mmbr.67.4.593-656.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Huang T-W, Chen T-L, Chen Y-T, Lauderdale T-L, Liao T-L, Lee Y-T, Chen C-P, Liu Y-M, Lin A-C, Chang Y-H, Wu K-M, Kirby R, Lai J-F, Tan M-C, Siu L-K, Chang C-M, Fung C-P, Tsai S-F. 2013. Copy number change of the NDM-1 sequence in a multidrug-resistant Klebsiella pneumoniae clinical isolate. PLoS One 8:e62774. doi: 10.1371/journal.pone.0062774. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Bertini A, Poirel L, Bernabeu S, Fortini D, Villa L, Nordmann P, Carattoli A. 2007. Multicopy blaOXA-58 gene as a source of high-level resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 51:2324–2328. doi: 10.1128/AAC.01502-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Nikaido H, Pagès JM. 2012. Broad specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev 36:340–363. doi: 10.1111/j.1574-6976.2011.00290.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Saw HTH, Webber MA, Mushtaq S, Woodford N, Piddock LV. 2016. Inactivation or inhibition of AcrAB-TolC increases resistance of carbapenemase-producing Enterobacteriaceae to carbapenems. J Antimicrob Chemother 71:1510–1519. doi: 10.1093/jac/dkw028. [DOI] [PubMed] [Google Scholar]
- 16.He S, Hickman AB, Varani AM, Siguier P, Chandler M, Dekker JP, Dyda F. 2015. Insertion sequence IS26 reorganizes plasmids in clinically isolated multidrug-resistant bacteria by replicative transposition. mBio 6:e00762-15. doi: 10.1128/mBio.00762-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Bedbrook JR, Ausubel FM. 1976. Recombination between bacterial plasmids leading to the formation of plasmid multimers. Cell 9:707–716. doi: 10.1016/0092-8674(76)90134-3. [DOI] [PubMed] [Google Scholar]
- 18.Mazin AV, Timchenko TV, Saparbaev MK, Mazina OM. 1996. Dimerization of plasmid DNA accelerates selection for antibiotic resistance. Mol Microbiol 20:101–108. doi: 10.1111/j.1365-2958.1996.tb02492.x. [DOI] [PubMed] [Google Scholar]
- 19.Wein T, Hülter NF, Mizrahi I, Dagan T. 2019. Emergence of plasmid stability under non-selective conditions maintains antibiotic resistance. Nat Commun 10:2595. doi: 10.1038/s41467-019-10600-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Summers DK, Sherratt DJ. 1984. Multimerization of high copy number plasmids causes instability: CoIE1 encodes a determinant essential for plasmid monomerization and stability. Cell 36:1097–1103. doi: 10.1016/0092-8674(84)90060-6. [DOI] [PubMed] [Google Scholar]
- 21.Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797–810. doi: 10.1016/j.cell.2007.06.049. [DOI] [PubMed] [Google Scholar]
- 22.Miller C, Thomsen LE, Gaggero C, Mosseri R, Ingmer H, Cohen SN. 2004. SOS response induction by beta-lactams and bacterial defense against antibiotic lethality. Science 305:1629–1631. doi: 10.1126/science.1101630. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The whole-genome sequencing data are available from the DNA Data Bank of Japan (DDBJ) under accession numbers AP019404, LC590858, and LC594662. Raw sequence data of DNA fractions extracted from ladder band gels are available at NCBI under accession numbers DRX229219 to DRX229222. Raw data of E044 sequenced by MinION for ultra-long-read sequencing is available at NCBI under accession number DRX264853.